Abiopharma

🔍 Alexander Andrea (Executive)

Company: DEVON ENERGY CORP/DE (DVN)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 61,829 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 61,829.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 47,350 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 109,179.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 22,951 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 132,130.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 24,399 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 156,529.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: On May 7, 2026, pursuant to the Agreement and Plan of Merger entered into on February 1, 2026, by and among Devon Energy Corporation (''Devon''), Coterra Energy Inc. (''Coterra") and Cubs Merger Sub, Inc. (the ''Merger Agreement''), as of the effective time of the transactions contemplated thereby (the "Effective Time"), Coterra became a wholly owned subsidiary of Devon. Pursuant to the Merger Agreement, at the Effective Time, each share of Coterra's common stock, par value $0.10 per share ("Coterra Common Stock") was converted into the right to receive 0.7 shares of Devon's common stock, par value $0.10 per share ("Devon Common Stock"), subject to certain exceptions.
• F2: Pursuant to the Merger Agreement, at the Effective Time, each time-based Coterra restricted stock unit ("Coterra RSU") outstanding and unvested as of immediately prior to the Effective Time was converted into 0.7 Devon time-based restricted stock units ("Devon RSUs"), with each Devon RSU representing a contingent right to receive a share of Devon Common Stock, subject to the same terms and conditions as were applicable to the corresponding Coterra RSU immediately prior to the Effective Time. The Coterra RSUs granted to the reporting person on February 24, 2026 were converted into 22,951 Devon RSUs, which will vest on January 31, 2029, and the Coterra RSUs granted to the reporting person on February 19, 2025 were converted into 24,399 Devon RSUs, which will vest on January 31, 2028.
• F3: These Devon RSUs relate to an award of Coterra performance stock units (a "Coterra PSU Award") that, pursuant to the Merger Agreement, at the Effective Time, was deemed earned at 100% of the target level as a result of the certification by the Compensation Committee of Coterra's board of directors to the actual level of performance achieved under the terms of such Coterra PSU Award prior to the Effective Time and was converted, on the same terms and conditions (other than any continuing performance-based vesting conditions and cash settlement features), into an award of Devon RSUs covering a number of shares of Devon Common Stock equal to the product of (i) the target number of shares of Coterra Common Stock subject to such Coterra PSU Award as of immediately prior to the Effective Time, multiplied by (ii) 0.7.
• F4: The Coterra PSU Award to which these Devon RSUs relate was granted to the reporting person on February 24, 2026 and, at the Effective Time, converted into 22,951 Devon RSUs, which will vest on January 31, 2029.
• F5: The Coterra PSU Award to which these Devon RSUs relate was granted to the reporting person on February 19, 2025 and, at the Effective Time, converted into 24,399 Devon RSUs, which will vest on January 31, 2028.